And Surterra Wellness, the company where Wrigley is CEO, has just spent a large chunk of capital to help achieve this goal.
Brown, who retired from Patrón in December after 20 years in December, has recently joined the board of Surterra as Managing Director.
With the last infusion, Surterra has raised a total of $ 350 million and continues to "curate" a leadership team with extensive experience in building and scaling businesses.
"Wrigley said in an interview with CNN Business.
Surterra pursues a tripartite strategy: accumulating operations and licenses on existing cannabis markets, developing a "branded house" that could sell globally, and promoting cannabis science and technology to disrupt not only sectors such as the beverage industry but also the healthcare industry This involves isolating various chemical compounds in the cannabis plant and tailoring them to different health and wellness needs.
"I truly believe in many ways that I'm building the next Wrigley Company," he said.
Surterra has been expanding since last fall, when Wrigley invested $ 65 million in the company and later took over as CEO. It has quickly evolved from being a medical cannabis license holder in Florida and Texas into a multi-national operator, brand developer and innovator in science and technology.
Earlier this week, Surterra acquired Molecular Infusions (Mi) of Boston, a developer of products for the treatment of cannabis, such as:] Privately-held Surterra does not share financial information, but Wrigley said the company is profitable.